447 related articles for article (PubMed ID: 28540751)
21. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
[TBL] [Abstract][Full Text] [Related]
22. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
[TBL] [Abstract][Full Text] [Related]
23. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.
Bindoli S; Baggio C; Doria A; Sfriso P
Drugs; 2024 Mar; 84(3):257-274. PubMed ID: 38441807
[TBL] [Abstract][Full Text] [Related]
24. Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S; Martínez-Quintanilla D; Martín-Varillas JL; García-Castañeda N; Atienza-Mateo B; González-Gay MA
Expert Opin Biol Ther; 2019 Apr; 19(4):273-286. PubMed ID: 30827128
[TBL] [Abstract][Full Text] [Related]
25. [Adult-onset Still's disease : Rare adult-onset autoinflammatory syndrome].
Oms E; Tronnier M
Hautarzt; 2019 Jul; 70(7):530-534. PubMed ID: 30937478
[TBL] [Abstract][Full Text] [Related]
26. Anakinra for the treatment of adult-onset Still's disease.
Castañeda S; Atienza-Mateo B; Martín-Varillas JL; Serra López-Matencio JM; González-Gay MA
Expert Rev Clin Immunol; 2018 Dec; 14(12):979-992. PubMed ID: 30324816
[TBL] [Abstract][Full Text] [Related]
27. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Sfriso P; Bindoli S; Galozzi P
Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
[TBL] [Abstract][Full Text] [Related]
28. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging biological therapy in adult-onset Still's disease.
Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
[TBL] [Abstract][Full Text] [Related]
30. About the complexity of adult onset Still's disease… and advances still required for its management.
Guilpain P; Le Quellec A
BMC Med; 2017 Jan; 15(1):5. PubMed ID: 28056958
[TBL] [Abstract][Full Text] [Related]
31. Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.
Li S; Zheng S; Tang S; Pan Y; Zhang S; Fang H; Qiao J
Clin Rev Allergy Immunol; 2020 Feb; 58(1):71-81. PubMed ID: 31147820
[TBL] [Abstract][Full Text] [Related]
32. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
33. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
[TBL] [Abstract][Full Text] [Related]
34. [Still's disease in adults: treatment with intravenous immunoglobulins].
Vignes S; Wechsler B
Rev Med Interne; 1999; 20 Suppl 4():419s-422s. PubMed ID: 10522316
[TBL] [Abstract][Full Text] [Related]
35. Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis--efficacy of interleukin-6 blockade and review of the literature.
Sabnis GR; Gokhale YA; Kulkarni UP
Semin Arthritis Rheum; 2011 Feb; 40(4):365-8. PubMed ID: 20621335
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease.
Franchini S; Dagna L; Salvo F; Aiello P; Baldissera E; Sabbadini MG
Arthritis Rheum; 2010 Aug; 62(8):2530-5. PubMed ID: 20506370
[TBL] [Abstract][Full Text] [Related]
37. Adult-onset Still's disease with prominent polyserositis.
Farooq Sheikh AS; Marks J; Hopkinson N
Scott Med J; 2018 May; 63(2):63-66. PubMed ID: 29506437
[TBL] [Abstract][Full Text] [Related]
38. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
39. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients.
Bodard Q; Langlois V; Guilpain P; Le Quellec A; Vittecoq O; Noel D; Eble V; Josse S; Schmidt J; Aouba A; Levesque H; Le Besnerais M; Benhamou Y
J Autoimmun; 2021 Jan; 116():102541. PubMed ID: 32943282
[TBL] [Abstract][Full Text] [Related]
40. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.
Kadavath S; Efthimiou P
Ann Med; 2015 Feb; 47(1):6-14. PubMed ID: 25613167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
